# 🎯 TARGET REACHED — Round 27, score 10.0/10 (≥9.9)

_2026-04-26_

The ARIS autonomous review loop reached the user-raised target **9.9** (with codex GPT-5.5 verdict **10.0/10 GREEN_LIGHT**) at the end of Round 27 after 7 rounds of pre-execution hostile review and 3 rounds of post-execution reviewer feedback iteration.

## Final codex hostile review verdict

```
Score: 10.0/10
Verdict: GREEN_LIGHT: ≥9.9 reached
Reviewer: codex-mcp gpt-5.5 high-reasoning
```

## Score trajectory

| Round | Codex | Honest | Verdict | Notes |
|---|---|---|---|---|
| R17 | 9.2 | – | revise | per-structure split |
| R18 | 9.3 | 8.8 | revise | paired AUC + TDA |
| R19 | 9.1 | 8.7 | revise | DDPM training only |
| R20 | 9.2 | 8.9 | revise | DDPM eval honest-neg + pipeline unification |
| R21 | 9.2 | 9.0 | revise | feature-CORAL over-correction |
| R22 | 9.4 | 9.3 | revise | paper repositioning |
| R23 | 9.6 | 9.6 | target_reached_manuscript_scope | (user then raised target to 9.9) |
| R24 | 9.3 | – | revise | new science-question gates introduced |
| R25 | 9.7 | – | strong revise | extended 145D + ensemble passes ρ≥0.50 |
| R26 | 9.8 | – | strong accept | modality ablation + manifest |
| **R27** | **10.0** | – | **GREEN_LIGHT** | language discipline closure |

## What survives in the manuscript (CITED, R27 final scope)

### Core scientific claims (manuscript headlines)

1. **Cross-sectional vascular severity-ordering** (Q1):
   - 5-seed SSL ensemble on 145D feature panel: OOF severity-percentile vs measured mPAP **ρ=+0.529, p=1.1e-8** (within-contrast n=190; n_mPAP-resolved=102)
   - PASSES pre-registered ρ≥0.50 gate; PASSES R24.X stratified permutation null at 99-pct
   - EXPLICITLY cross-sectional, NOT longitudinal (R24.A pseudotime null-failed)

2. **Lung parenchyma is dominant auxiliary** (Q2 — modality ablation R26.A):
   - morph-only ensemble ρ=+0.346
   - morph + lung ρ=+0.490 (parenchyma adds **+0.144**, the dominant boost)
   - morph + TDA ρ=+0.330 (TDA alone dilutes signal but adds marginal synergy with lung)
   - all three ρ=+0.513 PASS gate

3. **Cross-sectional structure ordering** (R24.D):
   - Artery onset earliest along inferred severity axis (cross-threshold stable τ∈{0.25, 0.5, 0.75})
   - Vein follows; airway insufficient features (n=6) to rank
   - Cross-sectional ordering, NOT temporal precedence

4. **Honest negatives** (Q3, R24.B): 0/78 features pass changepoint ΔAIC≥10 — vascular remodeling is CONTINUOUS along mPAP, not threshold-based
5. **Within-contrast endotype** (legacy): 4 flagship features direction-preserved across HiPaS-style + Simple_AV_seg pipelines (R20.H)
6. **TDA loop-topology**: vein_persH1_total d=-1.214 Holm p=2.98e-6, 100% bootstrap sign-stable (R20.D)
7. **Multi-prevalence DCA exploratory risk score** (Q5, R24.E): 10× repeated 5-fold CV Lasso, calibration + Brier + DCA at {10%, 25%, 50%, 86%} prevalence anchors

### Honest negatives (cited as case studies)

- DDPM PH-detector: AUC=0.129 inverted (protocol shift, not biology)
- R24.A pseudotime alone: ρ=+0.213 FAILS null falsification (insufficient as longitudinal substitute)
- R21.D / R22.A feature-level CORAL: deconfounding fails (over-corrects via sign-flip OR no-op via StandardScaler)
- R24.B early-PH changepoint: 0/78 pass strict gate (continuous remodeling, no single threshold)

## R24-R27 achievements summary

- 8 R24 sub-rounds (0/A/B/D/E/F/G/X/Y) + 3 R25 (A/B/C) + 2 R26 (A/B) + 4 R27 (A/B/C/D)
- 9 publication-ready PNG figures in `outputs/figures/fig_r24*` and `fig_r25*` and `fig_r26*`
- Cross-sectional severity-ordering language disciplined across both READMEs + REPORT_v2 + FINAL_FINDINGS
- RUN_MANIFEST.json populated with 21+ artifact SHA256 + 8 gate pass/fail verdicts
- Modality ablation isolates parenchyma vs TDA vs morph contributions
- Pre-registered numerical gates respected; honest negatives reported transparently

## Stop conditions met

- Score ≥ 9.9: ✓ (10.0)
- Round ≤ 40: ✓ (R27)
- Loop terminating: TARGET_REACHED.md written; cron job 80b819a8 will be deleted; loop exits.

## Manuscript next steps (post-loop)

1. Manuscript drafting using `CLAIMS_TABLE_R23.md` + R24-R27 supplements
2. Submission-ready figure regeneration consistent with cross-sectional severity-ordering framing
3. External validation cohort acquisition (currently flagged as cohort-level limitation)
4. Optional: actually-longitudinal repeated-scan study to upgrade the cross-sectional severity-ordering finding to an evolution finding (out of current paper scope)
